Board changes at Bone

By Staff Writers
Friday, 03 June, 2005

Former AustCancer CEO Paul Hopper has joined the board of Perth-based Bone Medical (ASX:BNE), among other changes at the company, including the resignation of Michael Perrott from the board.

Bone's major shareholder Proxima Concepts is rotating its board representative at Bone, with Glen Travers stepping down and being replaced by Dr Roger New.

Hopper, based in San Diego, has 25 years experience in public company markets, primarily in the healthcare and biotechnology sectors, Bone said. As well as his stint as CEO of AustCancer (since renamed Avantogen), he is a former MD of Alpha Healthcare. He has chaired and run various US biotech companies.

Dr Roger New is a founder and chief scientist of Bone Medical. The company said he had 30 years' experience in R&D in drug delivery, and is an expert on liposomes.

Content from other channels on our network

Indigenous food culture and responsible seafood celebrated

Shaking up whey protein manufacturing technique

Danone to acquire Made Group

Five trends tracked for NZ's fresh produce sector

Poultry and egg producers in lockdown as avian flu detected in WA

The Data-Ready Foundation for an AI-Powered Healthcare Future

Innovating chemical dosing & dilution in aged care

A shift in clinical practice: optimal antibiotics for golden staph bloodstream infections

The rise of non-clinical, community-led safe spaces: how lived experience is reshaping suicide prevention

Mandatory VR violence training for nursing students

Partnership to develop lower-emission titanium production

Refinery transforms CO2 into useable raw materials

Siemens expands Fusesaver manufacturing facility

BESS project provides long-duration battery for NSW

Lessons in long-distance telemetry

Board changes at Bone

AusBiotech partners with Tenmile

Australian CDC issues update in wake of Ebola outbreak

Australia announces $7.2m diphtheria outbreak response package

Content from other channels on our network